Fol. Biol. 2012, 58, 106-114

https://doi.org/10.14712/fb2012058030106

Xenogeneic Protein-Free Cultivation of Mesenchymal Stromal Cells – Towards Clinical Applications

David Stehlík1,2, R. Pytlík3, H. Rychtrmocová3, L. Kideryová3, R. Veselá3, Z. Kopečný1, T. Trč1, M. Trněný3

1Department of Children and Adult Orthopedic Surgery, Second Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
2Institute of Anatomy, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
3First Department of Medicine, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic

Received February 2011
Accepted December 2011

References

1. Abdallah, B. M., Kassem, M. (2009) The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. J. Cell. Physiol. 218, 9-12. <https://doi.org/10.1002/jcp.21572>
2. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., Galibert, L. (1997) A homologue of the TnF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179. <https://doi.org/10.1038/36593>
3. Benavente, C. A., Sierralta, W. D., Conget, P. A., Minguell, J. J. (2003) Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells. Growth Factors 21, 87-94. <https://doi.org/10.1080/08977190310001613789>
4. Connolly, J. F., Guse, R., Tiedeman, J., Dehne, R. (1989) Autologous marrow injection for delayed unions of the tibia: a preliminary report. J. Orthop. Trauma 3, 276-282. <https://doi.org/10.1097/00005131-198912000-00002>
5. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., Frolova, G. P. (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247. <https://doi.org/10.1097/00007890-196803000-00009>
6. Geng, T., Sun, H., Luo, F., Qi, N. (2008) Quantitative analysis of the responses of murine bone marrow mesenchymal stem cells to eGF, pDGF-BB and fibronectin by factorial design methodology. Cytotechnology 58, 93-101. <https://doi.org/10.1007/s10616-008-9172-x>
7. Goff, L. A., Boucher, S., Ricupero, C. L., Fenstermacher, S., Swerdel, M., Chase, L. G., Adams, C. C., Chesnut, J., Lakshmipathy, U., Hart, R. P. (2008) Differentiating human multipotent mesenchymal stromal cells regulate micrornAs: prediction of micrornA regulation by pDGF during osteogenesis. Exp. Hematol. 36, 1354-1369. <https://doi.org/10.1016/j.exphem.2008.05.004>
8. Gronthos, S., Simmons, P. J. (1995) The growth factor requirements of StRo-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85, 929-940. <https://doi.org/10.1182/blood.V85.4.929.bloodjournal854929>
9. Halme, D. G., Kessler, D. A. (2006) FDA regulation of stemcell-based therapies. N. Engl. J. Med. 355, 1730-1735. <https://doi.org/10.1056/NEJMhpr063086>
10. Hernigou, P., Poignard, A., Beaujean, F., Rouard, H. (2005) Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J. Bone Joint Surg. Am. 87, 1430-1437.
11. Jin-Xiang, F., Xiaofeng, S., Jun-Chuan, Q., Yan, G., Xue-Guang, Z. (2004) Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro. Exp. Hematol. 32, 1204-1211. <https://doi.org/10.1016/j.exphem.2004.08.005>
12. Kawate, K., Yajima, H., Ohgushi, H., Kotobuki, N., Sugimoto, K., Ohmura, T., Kobata, Y., Shigematsu, K., Kawamura, K., Tamai, K., Takakura, Y. (2006) Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif. Organs 30, 960-962. <https://doi.org/10.1111/j.1525-1594.2006.00333.x>
13. Koc, O. N., Gerson, S. L., Cooper, B. W., Dyhouse, S. M., Haynesworth, S. E., Caplan, A. I., Lazarus, H. M. (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18, 307-316. <https://doi.org/10.1200/JCO.2000.18.2.307>
14. Kratchmarova, I., Blagoev, B., Haack-Sorensen, M., Kassem, M., Mann, M. (2005) Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308, 1472-1477. <https://doi.org/10.1126/science.1107627>
15. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., Ringden, O. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441. <https://doi.org/10.1016/S0140-6736(04)16104-7>
16. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., Dini, G., Egeler, R. M., Bacigalupo, A., Fibbe, W., Ringden, O. (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versushost disease: a phase ii study. Lancet 371, 1579-1586. <https://doi.org/10.1016/S0140-6736(08)60690-X>
17. Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G., Kassem, M. (2008) Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies? Exp. Gerontol. 43, 1018-1023. <https://doi.org/10.1016/j.exger.2008.07.004>
18. Liberman, A. C., Druker, J., Perone, M. J., Arzt, E. (2007) Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev. 18, 45-56. <https://doi.org/10.1016/j.cytogfr.2007.01.005>
19. Lin, Y. M., Boccaccini, A. R., Polak, J. M., Bishop, A. E., Maquet, V. (2006) Biocompatibility of poly-DL-lactic acid (PDllA) for lung tissue engineering. J. Biomater. Appl. 21, 109-118. <https://doi.org/10.1177/0885328206057952>
20. Mannello, F., Tonti, G. A. (2007) Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25, 1603-1609. <https://doi.org/10.1634/stemcells.2007-0127>
21. Martin, F., Puertas, C., Thomas, M. C., Maranon, C., Patarroyo, M. E., Martin, J., Alonso, C., Lopez, M. C. (1997) Identification of a Trypanosoma cruzi antigenic epitope implicated in the infectivity of fibroblast LLCMk2 cells. Parasitol. Res. 83, 226-232.
22. Ng, F., Boucher, S., Koh, S., Sastry, K. S., Chase, L., Lakshmipathy, U., Choong, C., Yang, Z., Vemuri, M. C., Rao, M. S., Tanavde, V. (2008) pDGF, TGF-β, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112, 295-307. <https://doi.org/10.1182/blood-2007-07-103697>
23. Pal, R., Hanwate, M., Jan, M., Totey, S. (2009) Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. 3, 163-174. <https://doi.org/10.1002/term.143>
24. Purpura, K. A., Aubin, J. E., Zandstra, P. W. (2004) Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells 22, 39-50. <https://doi.org/10.1634/stemcells.22-1-39>
25. Pytlik, R., Purkrabkova, T., Stehlik, D., Hofman, P., Cervinkova, P., Obrtlikova, P., Zima, T., Trneny, M. (2005) Growth and differentiation of mesenchymal stem cells in human sera. Bone Marrow Transplant. 35, S77-S78.
26. Pytlik, R., Stehlik, D., Soukup, T., Kalbacova, M., Rypacek, F., Trc, T., Mulinkova, K., Michnova, P., Kideryova, L., Zivny, J., Klener, P., Jr., Vesela, R., Trneny, M., Klener, P. (2009) the cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering. Biomaterials 30, 3415-3427. <https://doi.org/10.1016/j.biomaterials.2009.03.001>
27. Rydziel, S., Shaikh, S., Canalis, E. (1994) Platelet-derived growth factor-AA and -BB (PDGF-AA and -BB) enhance the synthesis of PDGF-AA in bone cell cultures. Endocrinology 134, 2541-2546. <https://doi.org/10.1210/endo.134.6.8194480>
28. Sato, H., Takahashi, M., Ise, H., Yamada, A., Hirose, S., Tagawa, Y., Morimoto, H., Izawa, A., Ikeda, U. (2006) Collagen synthesis is required for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 342, 107-112. <https://doi.org/10.1016/j.bbrc.2006.01.116>
29. Seko, N., Yoshino, K., Yokota, K., Tsukamoto, G. (1991) Synthesis and platelet aggregation inhibitory activity of diphenylazole derivatives. i. thiazole and imidazole derivatives. Chem. Pharm. Bull. (Tokyo) 39, 651-657. <https://doi.org/10.1248/cpb.39.651>
30. Solchaga, L. A., Penick, K., Porter, J. D., Goldberg, V. M., Caplan, A. I., Welter, J. F. (2005) FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J. Cell. Physiol. 203, 398-409. <https://doi.org/10.1002/jcp.20238>
31. Tamama, K., Kawasaki, H., Wells, A. (2010) epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J. Biomed. Biotechnol. 2010, 795385. <https://doi.org/10.1155/2010/795385>
32. Tonti, G. A., Mannello, F. (2008) From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int. J. Dev. Biol. 52, 1023-1032. <https://doi.org/10.1387/ijdb.082725gt>
33. Tsuji, K., Bandyopadhyay, A., Harfe, B. D., Cox, K., Kakar, S., Gerstenfeld, L., Einhorn, T., Tabin, C. J., Rosen, V. (2006) BMp2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38, 1424-1429. <https://doi.org/10.1038/ng1916>
34. Tsutsumi, S., Shimazu, A., Miyazaki, k., Pan, h., koike, C., yoshida, E., takagishi, k., kato, y. (2001) Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem. Biophys. Res. Commun. 288, 413-419. <https://doi.org/10.1006/bbrc.2001.5777>
35. Unger, C., Skottman, H., Blomberg, P., Dilber, M. S., Hovatta, O. (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17(r1), r48-53. <https://doi.org/10.1093/hmg/ddn079>
36. Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., Ho, A. D. (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3, e2213. <https://doi.org/10.1371/journal.pone.0002213>
37. Yoo, J., Shanmugam, S., Song, C. K., Kim, D. D., Choi, H. G., Yong, C. S., Woo, J. S., Yoo, B. K. (2008) Skin penetration and retention of L-ascorbic acid 2-phosphate using multilamellar vesicles. Arch. Pharm. Res. 31, 1652-1658. <https://doi.org/10.1007/s12272-001-2164-4>
38. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D. (1990) the murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442-444. <https://doi.org/10.1038/345442a0>
39. Yu, Y. Y., Lieu, S., Lu, C., Miclau, T., Marcucio, R. S., Colnot, C. (2010) Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 46, 841-851. <https://doi.org/10.1016/j.bone.2009.11.005>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive